OSCR EBITDA | Oscar Health, Inc.

Oscar Health, Inc. (OSCR) EBITDA

2026-06-30: Basis Reported; EBITDA $394.67M*; Operating income $388.63M; Depreciation and amortization $6.03M*.
2026-03-31: Basis Reported; EBITDA $711.1M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$325.87M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$121.94M*; Operating income -$129.25M; Depreciation and amortization $7.31M*.

Complete source-backed ebitda history.

Available history: 2019-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$394.67M*	$388.63M	$6.03M*	$6.09M	6475.24%*	(m)	$2.09B*	(m)	(m)	$691.08M	$21.18M
2026-03-31	Reported	$711.1M	(m)	(m)	(m)	12436.22%	(m)	$2.62B	(m)	(m)	$706.23M	$19.75M
2025-12-31	Reported	-$325.87M	(m)	(m)	(m)	-3634.88%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$121.94M*	-$129.25M	$7.31M*	$8.80M	-1385.50%*	(m)	-$964.66M*	(m)	(m)	$521.59M	-$1.81M
2025-06-30	Reported	-$223.51M*	-$230.48M	$6.97M*	$6.50M	-3440.25%*	(m)	$509.07M*	(m)	(m)	$534.49M	-$5.04M
2025-03-31	Reported	$303.85M	(m)	(m)	(m)	7017.39%	(m)	$878.54M	(m)	(m)	$482.76M	$12.71M
2024-12-31	Reported	-$138.5M	(m)	(m)	(m)	-2878.18%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$40.87M*	-$48.37M	$7.50M*	$4.90M	-834.33%*	(m)	-$500.14M*	(m)	(m)	$460.38M	$2.08M
2024-06-30	Reported	$75.41M*	$67.81M	$7.60M*	$5.23M	1441.66%*	(m)	$497.15M*	(m)	(m)	$435.21M	$4.64M
2024-03-31	Reported	$193.37M	(m)	(m)	(m)	3432.18%	(m)	$634.36M	(m)	(m)	$394.16M	$996.00K
2023-12-31	Reported	-$137.74M	(m)	(m)	(m)	-2406.27%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$49.05M*	-$58.24M	$9.19M*	$5.54M	-885.27%*	(m)	-$1.15B*	(m)	(m)	$325.85M	$915.00K
2023-06-30	Reported	$2.29M*	-$6.53M	$8.82M*	$5.08M	45.09%*	(m)	$165.52M*	(m)	(m)	$337.24M	$1.16M
2023-03-31	Reported	-$20.43M	(m)	(m)	(m)	-408.28%	(m)	$414.71M	(m)	(m)	$398.52M	$2.02M
2022-12-31	Reported	-$218.74M	(m)	(m)	(m)	-3334.00%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$188.31M*	-$192.37M	$4.06M*	$19.42M	-969.64%*	(m)	-$548.36M*	(m)	(m)	(m)	-$1.61M
2022-06-30	Reported	-$102.80M*	-$106.49M	$3.69M*	$20.45M	-502.62%*	(m)	$214.47M*	(m)	(m)	(m)	$290.00K
2022-03-31	Reported	-$64.73M	(m)	(m)	(m)	-350.02%	(m)	$562.85M	(m)	(m)	(m)	$1.52M
2021-12-31	Reported	-$192.28M	(m)	(m)	(m)	-6100.38%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$208.03M*	-$211.68M	$3.65M*	$1.55M	-13438.95%*	(m)	-$589.25M*	(m)	(m)	(m)	-$597.00K
2021-06-30	Reported	-$68.92M*	-$72.51M	$3.59M*	$353.00K	-19523.80%*	(m)	$55.34M*	(m)	(m)	(m)	$589.00K
2021-03-31	Reported	-$60.64M	(m)	(m)	(m)	-17782.40%	(m)	$317.69M	(m)	(m)	(m)	$965.00K
2020-12-31	Reported	-$183.54M	(m)	(m)	(m)	60.15%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$77.20M*	-$80.13M	$2.92M*	(m)	(m)	(m)	-$218.92M*	(m)	(m)	(m)	-$998.00K
2020-06-30	Reported	-$36.83M*	-$39.35M	$2.52M*	(m)	(m)	(m)	$246.32M*	(m)	(m)	(m)	$1.59M
2020-03-31	Reported	-$93.4M	(m)	(m)	(m)	-106.02%	(m)	$106.35M	(m)	(m)	(m)	$931.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$367.47M	(m)	(m)	(m)	-1285.16%	(m)	$1.09B	(m)	(m)	$2.05B	$5.61M
2024-12-31	Reported	$89.41M	(m)	(m)	(m)	434.54%	(m)	$978.19M	(m)	(m)	$1.76B	$7.30M
2023-12-31	Reported	-$204.92M	(m)	(m)	(m)	-959.68%	(m)	-$272.16M	(m)	(m)	$1.43B	$3.29M
2022-12-31	Reported	-$574.58M	(m)	(m)	(m)	-884.97%	(m)	$380.35M	(m)	(m)	$1.26B	-$523.00K
2021-12-31	Reported	-$529.88M	(m)	(m)	(m)	-9823.43%	(m)	-$181.75M	(m)	(m)	(m)	$846.00K
2020-12-31	Reported	-$390.98M	(m)	(m)	(m)	(m)	(m)	$222.73M	(m)	(m)	(m)	$1.04M
2019-12-31	Reported	-$252.49M	(m)	(m)	(m)	-51.72%	(m)	-$165.37M	(m)	(m)	(m)	$1.79M